BDBM772104 Preparation of 4-((2R,4s,6S)-2-cyano-7-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)-7-azaspiro[3.5]nonan-6-yl)benzoic acid and 4-((2S,4r,6S)-2-cyano-7-((5-methoxy-7-methyl-1H-indol-4-yl)methyl)-7-azaspiro[3.5]nonan-6-yl)benzoic acid::US20250289804, Example 52

SMILES COc1cc(C)c2[nH]ccc2c1CN1CC[C@]2(C[C@H]1c1ccc(C(=O)O)cc1)C[C@@H](C#N)C2

InChI Key

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 772104   

TargetComplement receptor type 1/B/D(Human)
Novartis Pharma

US Patent
LigandPNGBDBM772104(Preparation of 4-((2R,4s,6S)-2-cyano-7-((5-methoxy...)
Affinity DataIC50: 100nMMore data for this Ligand-Target Pair
Target InfoPDB
GoogleScholar
Ligand Info
In Depth
Date in BDB:
TBA
Entry Details
US Patent